Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure

NCT05248022 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

PROCEDURE: Drug-eluting beads bronchial arterial chemoembolization
DRUG: Programmed Cell Death Protein 1 Inhibitor

Sponsor

The Central Hospital of Lishui City

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]